Eric Lefebvre, Chief Medical Officer at PLIANT THERAPEUTICS, INC. (PLRX), sold 22,490 shares at $26.52 ($596K) on 2023-03-30, disclosed to the SEC on 2023-04-03.
Scheduled sale ($596k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.52 | 11,245 | $298K | 50.0% |
| 2 | $26.52 | 11,245 | $298K | 50.0% |
| Total | $26.52 avg | 22,490 | $596K | 100% |
| Filing → |
| PLRX | SELL | 2024-01-19 | $355K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $804K | — | Filing → |
| PLRX | SELL | 2023-01-25 | $2.3M | — | Filing → |